Evidence map›Paper›PMID 41302936›Full record

ArticleJournal of clinical medicine2025

ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit.

Carlos Martínez-Rivera, Marina Blanco-Aparicio, Francisco Casas-Maldonado, Fernando Sánchez-Toril López, Marta Palop-Cervera, Luis F Cassini, Jose Luis Sanchez-Trincado, Elisa Luzon, Javier Nuevo, Laia Secall and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Carlos Martínez-RiveraHospital Universitario Germans Trias i Pujol, Carretera de Canyet, S/N, 08916 Badalona, Spain.ORCID 0000-0003-1031-2561
Marina Blanco-AparicioHospital Universitario de A Coruña, As Xubias, 84, 15006 A Coruña, Spain.ORCID 0000-0002-5012-1746
Francisco Casas-MaldonadoHospital Universitario Clínico San Cecilio, Av. del Conocimiento, S/N, 18007 Granada, Spain.ORCID 0000-0002-8007-9323
Fernando Sánchez-Toril LópezHospital Arnau de Vilanova-Lliria, Carrer de Sant Clement, 12, Campanar, 46015 Valencia, Spain.
Marta Palop-CerveraHospital de Sagunto, Av. Ramon i Cajal, S/N, 46520 Sagunto, Spain.
Luis F CassiniHospital Universitario Clínico San Cecilio, Av. del Conocimiento, S/N, 18007 Granada, Spain.
Jose Luis Sanchez-TrincadoMedical Department, AstraZeneca Farmacéutica S.A, Calle del Puerto de Somport, 21-23, 28050 Madrid, Spain.ORCID 0000-0002-9150-1315
Elisa LuzonMedical Department, AstraZeneca Farmacéutica S.A, Calle del Puerto de Somport, 21-23, 28050 Madrid, Spain.ORCID 0009-0003-3007-8255
Javier NuevoMedical Department, AstraZeneca Farmacéutica S.A, Calle del Puerto de Somport, 21-23, 28050 Madrid, Spain.
Laia SecallMedical Department, AstraZeneca Farmacéutica S.A, Calle del Puerto de Somport, 21-23, 28050 Madrid, Spain.
Marta González-SierraMedical Department, AstraZeneca Farmacéutica S.A, Calle del Puerto de Somport, 21-23, 28050 Madrid, Spain.
Carmen Paula BarragánMedical Department, AstraZeneca Farmacéutica S.A, Calle del Puerto de Somport, 21-23, 28050 Madrid, Spain.
Alicia Padilla-GaloHospital Universitario Virgen de la Victoria, Campus de Teatinos, S/N, 29010 Malaga, Spain.ORCID 0000-0003-4625-2716

Funding

AstraZeneca (Spain) NA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

airflow obstructionbenralizumabobservationalORBE IIreal worldsevere eosinophilic asthmasmoking

Identifiers

PMID41302936
PMCPMC12653045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.